Eledon Pharmaceuticals, Inc. (ELDN) Misses Q1 EPS by 15c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q1 EPS of ($0.75), $0.15 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• Ciena beats estimates on strong AI-driven demand, shares rise
• Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance
• Lands' End (LE) Tops Q2 EPS by 1c